$1.45
3.97% yesterday
Nasdaq, Apr 28, 10:03 pm CET
ISIN
US14161W1053
Symbol
CDLX

Cardlytics, Inc. Stock price

$1.45
-0.40 21.62% 1M
-2.59 64.11% 6M
-2.26 60.92% YTD
-11.50 88.80% 1Y
-34.03 95.91% 3Y
-45.49 96.91% 5Y
-11.92 89.15% 10Y
Nasdaq, Closing price Mon, Apr 28 2025
-0.06 3.97%
ISIN
US14161W1053
Symbol
CDLX

Key metrics

Market capitalization $75.65m
Enterprise Value $231.71m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.83
P/S ratio (TTM) P/S ratio 0.27
P/B ratio (TTM) P/B ratio 1.06
Revenue growth (TTM) Revenue growth -10.00%
Revenue (TTM) Revenue $278.30m
EBIT (operating result TTM) EBIT $-63.53m
Free Cash Flow (TTM) Free Cash Flow $-10.39m
Cash position $65.59m
EPS (TTM) EPS $-3.86
P/E forward negative
P/S forward 0.28
EV/Sales forward 0.85
Short interest 18.65%
Show more

Is Cardlytics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Cardlytics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Cardlytics, Inc. forecast:

5x Hold
83%
1x Sell
17%

Analyst Opinions

6 Analysts have issued a Cardlytics, Inc. forecast:

Hold
83%
Sell
17%

Financial data from Cardlytics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
278 278
10% 10%
100%
- Direct Costs 153 153
13% 13%
55%
125 125
6% 6%
45%
- Selling and Administrative Expenses 111 111
4% 4%
40%
- Research and Development Expense 50 50
3% 3%
18%
-36 -36
2% 2%
-13%
- Depreciation and Amortization 28 28
2% 2%
10%
EBIT (Operating Income) EBIT -64 -64
0% 0%
-23%
Net Profit -189 -189
41% 41%
-68%

In millions USD.

Don't miss a Thing! We will send you all news about Cardlytics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cardlytics, Inc. Stock News

Neutral
Business Wire
4 days ago
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on April 24, 2025, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 124,050 restricted stock units of Cardlytics to 11 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)...
Neutral
Business Wire
6 days ago
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the first quarter ending March 31, 2025 will be released on May 7, 2025, after market close. Conference Call Details: When: May 7, 2025 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardl...
Neutral
GlobeNewsWire
about 2 months ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cardlytics To Contact Him Directly To Discuss Their Options
More Cardlytics, Inc. News

Company Profile

Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Head office United States
CEO Amit Gupta
Employees 454
Founded 2008
Website www.cardlytics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today